Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme

This website provides information about prion disease, prion disease research, and related subjects. All information posted is for educational and informational purposes and it is not intended as a substitute for advice from a healthcare professional. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options for prion disease.

Reference to any specific clinical trial, entity, or treatment options does not constitute endorsement or recommendation by the CJISA or its members.

While the information on this website has been verified to the best of our ability, we cannot guarantee that there are no errors or mistakes. Should you decide to act upon any information on this website, you do so at your own risk.